Venous thromboembolism in Asia -an unrecognised and under-treated problem?

Thrombosis and Haemostasis

Volumn 106, Issue 4, 2011, Pages 585-590

  Angchaisuksiri, Pantep ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Asia; Far east; Venous thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ABDOMINAL SURGERY; ARTICLE; ASIA; ASIAN; CAUCASIAN; DEEP VEIN THROMBOSIS; ETHNIC DIFFERENCE; GENE MUTATION; GENETIC DIFFERENCE; GENETIC PREDISPOSITION; GENETIC RISK; HIGH RISK PATIENT; HIP ARTHROPLASTY; HIP FRACTURE; HUMAN; INCIDENCE; LUNG EMBOLISM; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; THROMBOSIS PREVENTION; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

ANTITHROMBIN III DEFICIENCY; ASIA; FACTOR V; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MUTATION; POLYMORPHISM, GENETIC; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 80053203135     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-03-0184     Document Type: Article

References (69)

1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl): 381S-453S.
2. Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. 2010; pp. 216-220.
3. Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2011; 364: 351-360.
4. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-394.
5. Hwang WS. The rarity of pulmonary thromboembolism in Asians. Singapore Med J 1968; 9: 276-279.
6. Chumnijarakij T. Poshyachinda V. Post-operative thrombosis in Thai women. Lancet 1975; 1: 1357-1358.
7. Nandi P, Wong KP, Wei WI, et al. Incidence of post operative deep vein thrombosis in Hong Kong Chinese. Br J Surg 1980; 67: 251-253.
8. Inada K, Shirai N, Hayashi M, et al. Postoperative deep venous thrombosis in Japan. Incidence and prophylaxis. Am J Surg 1983; 145: 775-779.
9. Atichartakarn V, Pathepchotiwong K, Eurvilaichit C. Deep vein thrombosis after hip surgery among Thai. Arch Intern Med 1988; 148: 1349-1353.
10. Stein PD, Kayali F, Olson RE, et al. Pulmonary thromboembolism in Asians/ Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 2004; 116: 435-442.
11. White RH, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
12. Schneider D, Lillenfield DE, Im W. The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. J Natl Med Assoc 2006; 98: 1967-1972.
13. Leizorovicz A, Turpie AGG, Cohen AT, et al. Epidemiology of post-operative venous thromboembolism in Asian countries. Int J Angiol 2004; 13: 101-108.
14. Leizorovicz A, Turpie AGG, Cohen AT, et al. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study. J Thromb Haemost 2005; 3: 28-34.
15. A, on behalf of the SMART Venography Study Steering Committee. Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study. Haematologica 2007; 92: 1194-200.
16. Piovella F, Wang C-J, Lu H, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost 2005; 3: 2664-2670.
17. Sakon M, Maehara Y, Yoshikawa H, et al. Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan. J Thromb Haemost 2006; 4: 581-586.
18. Cheng Y, Wong R, Lam J, et al. Estimated risk of deep venous thrombosis among Chinese patients admitted to general medical wards. J Thromb Haemost 2004; 2: 1666-1668.
19. Leung V, Leung V, Lui W, et al. Incidence of deep vein thrombosis in hospitalized Chinese medical patients is similar to that in western populations. Thromb Res 2006; 118: 763-764.
20. Ng HJ, Lee LH. Trends in prevalence of deep venous thrombosis among hospitalized patients in an Asian institution. Thromb Haemost 2009; 101: 1095-1099.
21. Aniwan S, Rojnuckarin P. High incidence of symptomatic venous thromboembolism in Thai hospitalized medical patients without thromboprophylaxis. Blood Coagul Fibrinolysis 2010; 21: 334-338.
22. Jang MJ, Bang S-M, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2011; 9: 85-91.
23. Liu YEB, Hu S, Chan SP, et al. The epidemiology and surgical outcomes of patients undergoing primary total hip replacement: an Asian perspective. Singapore Med J 2009; 50: 15-19.
24. Samama CM, Clergue F, Barre J, et al. Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery. Br J Anaesth 1997; 78: 660-665.
25. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of deep vein thrombosis after major knee surgery - a randomized, double-blind trial comparing a low mo-lecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 1992; 67: 417-423.
26. Agnelli G, Cosmi B, Filippo PD, et al. A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost 1992; 67: 203-208.
27. Ockelford PA, Patterson J, Johns AS. A double-blind randomized placebo controlled trial of thromboprophylaxis in major elective general surgery using once daily injections of a low molecular weight heparin fragment (Fragmin). Thromb Haemost 1989; 62: 1046-1049.
28. Alikhan R, Peters F, Wilmott R, et al. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol 2004; 57: 1254-1257.
29. Dunn AS, Brenner A, Halm EA. The magnitude of an iatrogenic disorder: a systematic review of the incidence of venous thromboembolism for general medical inpatients. Thromb Haemost 2006; 95: 758-762.
30. AT, on behalf of the Asia-Pacific Thrombosis Advisory Board. Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery. Thromb Haemost 2010; 104: 919-930.
31. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-1231.
32. Margaglione M, Grandone E. Population genetics of venous thromboembolism. Thromb Haemost 2011; 105: 221-231.
33. Angchaisuksiri P, Pingsuthiwong S, Aryurachai K, et al. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Hematol 2000; 65: 119-122.
34. Lu Y, Zhao Y, Liu G, et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res 2002; 106: 7-12.
35. Takamiya O, Ishida F, Kodaira H, et al. APC-resistance and Mnl1 genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995; 74: 996.
36. Miyata T, Kawasaki T, Fujimura H, et al. The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals. Blood Coagul Fibrinolysis 1998; 9: 451-452.
37. Angchaisuksiri P, Atichartakarn V, Aryurachai K, et al. Risk factors of Thai patients with venous thromboembolism. Int J Hematol 2007; 86: 397-402.
38. Chen TY, Su WC, Tsao CJ. Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis. Ann Hematol 2003; 82: 114-117.
39. Miyata T, Sato Y, Ishikawa J, et al. Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis. Thromb Res 2009; 124: 14-18.
40. Suehisa E, Nomura T, Kawasaki T, et al. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis 2001; 12: 95-99.
41. Akkawat B, Rojnuckarin P. Protein S deficiency is common in a healthy Thai population. J Med Assoc Thai 2005; 88 (Suppl 4): S249-S254.
42. Zhu T, Ding Q, Bai X, et al. Normal ranges and genetic underlying variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group. Haematologica 2011; 96: 1033-1040.
43. Miyata T, Kimura R, Kokubo Y, et al. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol 2006; 83: 217-223.
44. Castoldi E, Rosing J. APC resistance: biological basis and acquired influences. J Thromb Haemost 2010; 8: 445-453.
45. Williamson D, Brown K, Luddington R, et al. Factor V Cambridge: a new mutation (Arg306 to Thr) associated with resistance to activated protein C. Blood 1998; 91: 1140-1144.
46. Mumford AD, McVey JH, Morse CV, et al. Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. Br J Haematol 2003; 123: 496-501.
47. Liang R, Lee CK, Wat MS, et al. Clinical significance of Arg306 mutation of factor V gene. Blood 1998; 92: 2599-2600.
48. Angchaisuksiri P, Inkaew B, Busabaratana M, et al. The factor V R2 allele (A4070G), factor V gene G1628A mutation, factor V Hong Kong (A1090G), factor V Cambridge (G1091C), the tissue factor pathway inhibitor gene C536T mutation and the risk of venous thrombosis in Thai patients. J Thromb Haemost (Suppl) 2003; Abstract P0366.
49. Bernardi F, Faioni EM, Castoldi E, et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997; 90: 1552-1557.
50. Okada H, Toyoda Y, Takagi A, et al. Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype. Int J Hematol 2010; 91: 549-550.
51. Castaman G, Faioni EM, Tosetto A, et al. The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis. Haematologica 2003; 88: 1182-1189.
52. Cai H, Hua B, Fan L, et al. A novel mutation (G2172 to C) in the factor V gene in a Chinese family with hereditary activated protein C resistance. Thromb Res 2010; 125: 545-548.
53. Kodaira H, Ishida F, Shimodaira S, et al. Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations. Acta Haematol 1997; 98: 22-25.
54. Zama T, Murata M, Ono F, et al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals. Int J Hematol 1996; 65: 71-78.
55. Yanqing H, Fangping C, Qinzhi X, et al. No association between thrombosis and factor V gene polymorphisms in Chinese Han population. Thromb Haemost 2003; 89: 446-451.
56. Mutirangura P, Rüengsethakit C, Wongwanit C. Epidemiologic analysis of proximal deep vein thrombosis in Thai patients: Malignancy, the predominant etiologic factor. Int J Angio 2004; 13: 81-83.
57. Peng YY, Jeng JS, Shen MC, et al. Aetiologies and prognosis of Chinese patients with deep vein thrombosis of the lower extremities. QJM 1998; 91: 681-686.
58. Lee HC, Liao WB, Bullard MJ, et al. Deep vein thrombosis in Taiwan. Jpn Heart J1996; 37: 891-896.
59. Lee C-H, Lin L-J, Cheng C-L, et al. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost 2010; 8: 1515-1523.
60. Bhoopat L, Rojnuckarin P, Hiransuthikul N, et al. Low vegetable intake is strongly associated with venous thromboembolism in Thai population. Blood Coagul Fibrinolysis 2010: 21: 758-763.
61. Broekmans WM, Klöpping-Ketelaars IA, Schuurman CR, et al. Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J Nutr 2000; 130: 1578-1583.
62. McCully K. Homocysteine, folate, vitamin B6, and cardiovascular disease. J Am Med Assoc 1998; 279: 392-393.
63. Cattaneo M, Lombardi R, Lecchi A, et al. Low plasma levels of vitamin B6 are independently associated with a heightened risk of deep-vein thrombosis. Circulation 2001; 104: 2442-2446.
64. Shahar E, Folsom AR, Wu KK, et al. Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993; 13: 1205-1212.
65. Visudhiphan S, Poolsuppasit S, Piboonnukarinir O, et al. The relationship between high fibrinolytic activity and daily capsicum ingestion in Thais. Am J Clin Nutr 1982; 35: 1452-1455.
66. Wang JP, Hsu MF, Hsu TP, et al. Antihemostatic and antithrombotic effects of capsaicin in comparison with aspirin and indomethacin. Thromb Res 1985; 37: 669-679.
67. Steffen LM, Folsom AR, Cushman M, et al. Greater fish, fruit and vegetable intakes are related to lower incidence of venous thromboembolism: The longitudinal investigation of thromboembolism etiology. Circulation 2007; 115: 188-195.
68. Jacobs DR, Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: issues and challenges. Am J Clin Nutr 2003; 78 (Suppl): 508S-513S.
69. Bang SM, Jang MJ, Oh D, et al. Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci 2010; 25: 1553-1559.